Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells.

Parasido E, Avetian GS, Naeem A, Graham G, Pishvaian M, Glasgow E, Mudambi S, Lee Y, Ihemelandu C, Choudhry M, Peran I, Banerjee PP, Avantaggiati ML, Bryant K, Baldelli E, Pierobon M, Liotta L, Petricoin E, Fricke ST, Sebastian A, Cozzitorto J, Loots GG, Kumar D, Byers S, Londin E, DiFeo A, Narla G, Winter J, Brody JR, Rodriguez O, Albanese C.

Mol Cancer Res. 2019 Sep;17(9):1815-1827. doi: 10.1158/1541-7786.MCR-19-0191. Epub 2019 Jun 4.

PMID:
31164413
2.

Management of malignancy-associated bowel obstruction by cervical esophagostomy and total parenteral nutrition, case series of 2 patients.

Sugarbaker PH, Khaitan PG, Ihemelandu C.

Int J Surg Case Rep. 2018;53:390-393. doi: 10.1016/j.ijscr.2018.11.016. Epub 2018 Nov 16.

4.

Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells.

Tricoli L, Naeem A, Parasido E, Mikhaiel JP, Choudhry MU, Berry DL, Abdelgawad IA, Lee RJ, Feldman AS, Ihemelandu C, Avantaggiati M, Kumar D, Byers S, Gallagher R, Wulfkuhle J, Petricoin E, Rodriguez O, Albanese C.

Oncotarget. 2017 Dec 18;9(2):2193-2207. doi: 10.18632/oncotarget.23363. eCollection 2018 Jan 5.

5.

Why Do Long-Distance Travelers Have Improved Pancreatectomy Outcomes?

Jindal M, Zheng C, Quadri HS, Ihemelandu CU, Hong YK, Smith AK, Dudeja V, Shara NM, Johnson LB, Al-Refaie WB.

J Am Coll Surg. 2017 Aug;225(2):216-225. doi: 10.1016/j.jamcollsurg.2017.04.003. Epub 2017 Apr 14.

6.

A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Ihemelandu C, Fernandez S, Sugarbaker PH.

Ann Surg Oncol. 2017 Aug;24(8):2266-2272. doi: 10.1245/s10434-017-5847-x. Epub 2017 Mar 24.

PMID:
28342015
8.
10.

Multimorbidity and access to major cancer surgery at high-volume hospitals in a regionalized era.

Ihemelandu C, Zheng C, Hall E, Langan RC, Shara N, Johnson L, Al-Refaie W.

Am J Surg. 2016 Apr;211(4):697-702. doi: 10.1016/j.amjsurg.2015.09.017. Epub 2016 Feb 28.

12.

Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results.

Sugarbaker P, Ihemelandu C, Bijelic L.

Ann Surg Oncol. 2016 May;23(5):1501-7. doi: 10.1245/s10434-015-4960-y. Epub 2015 Nov 6.

PMID:
26545375
13.
14.

Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality.

Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2013 Oct;20(11):3497-503. doi: 10.1245/s10434-013-3053-z. Epub 2013 Jun 19.

15.

Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status.

Ihemelandu CU, McQuellon R, Shen P, Stewart JH, Votanopoulos K, Levine EA.

Ann Surg Oncol. 2013 Oct;20(11):3519-26. doi: 10.1245/s10434-013-3049-8. Epub 2013 Jun 8.

PMID:
23748607
16.

Optimal timing of systemic therapy in resectable colorectal liver metastases.

Ihemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton R, Bolemon B, Graham M, Russell G, Shen P.

Am Surg. 2013 Apr;79(4):414-21.

17.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer.

Votanopoulos KI, Swett K, Blackham AU, Ihemelandu C, Shen P, Stewart JH, Levine EA.

Ann Surg Oncol. 2013 Apr;20(4):1088-92. doi: 10.1245/s10434-012-2787-3. Epub 2013 Mar 2.

18.

Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA.

J Am Coll Surg. 2012 Sep;215(3):412-7. doi: 10.1016/j.jamcollsurg.2012.04.023. Epub 2012 May 26.

19.

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.

Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA.

J Surg Res. 2013 Jan;179(1):e133-9. doi: 10.1016/j.jss.2012.01.015. Epub 2012 Mar 10.

20.

Management of peritoneal carcinomatosis from colorectal cancer.

Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA.

Semin Oncol. 2011 Aug;38(4):568-75. doi: 10.1053/j.seminoncol.2011.05.011. Review.

21.

Clinical significance of p53 and bcl-2 protein coexpression phenotypes in molecular breast cancer subtypes of pre-menopausal and post-menopausal African-American women.

Ihemelandu CU, Dewitty RL Jr, Leffall LD Jr, Suryanarayana SM, Frederick WA.

Am Surg. 2009 Sep;75(9):776-84; discussion 784.

PMID:
19774948
22.

Trends in clinicopathologic characteristics and prognostic predictors of survival outcome in black patients with gastric carcinoma: a single institution's experience.

Ihemelandu CU, DeWitty RL Jr, Leffall LD Jr, Suryanarayana MS, Frederick WA.

J Surg Res. 2009 Oct;156(2):325-32. doi: 10.1016/j.jss.2009.03.097. Epub 2009 May 12.

PMID:
19691978
23.

Treatment and survival outcome for molecular breast cancer subtypes in black women.

Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD Jr, DeWitty RL Jr, Frederick WA.

Ann Surg. 2008 Mar;247(3):463-9. doi: 10.1097/SLA.0b013e31815d744a.

PMID:
18376191
24.

Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women.

Ihemelandu CU, Naab TJ, Mezghebe HM, Makambi KH, Siram SM, Leffall LD Jr, Dewitty RL Jr, Frederick WA.

Am J Surg. 2008 Feb;195(2):153-8.

PMID:
18083134
25.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

J Surg Res. 2007 Nov;143(1):109-18.

PMID:
17950079
26.

Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

Ann Surg Oncol. 2007 Oct;14(10):2994-3003. Epub 2007 Jul 24.

PMID:
17647064

Supplemental Content

Loading ...
Support Center